Personalized Stem Cell-Based Regeneration in Spinal Cord Injury Care
International Journal of Molecular Sciences · 19.04.2025 · 26 (8) · 3874
DOI: 10.3390/ijms26083874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.04.2025. Verfasst von Sasi Kumar Jagadeesan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Precision Medicine, Stem Cell Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Josette Robertson and Joan Johnston Family Foundation Fund, Michael T. Richard Clinical Research Fellowship in Neurosurgery, Department of Surgery at the University of Ottawa.
Abstract (Originalsprache)
Spinal cord injury (SCI) remains a major clinical challenge, with limited therapeutic options for restoring lost neurological function. While efforts to mitigate secondary damage have improved early-phase management, achieving sustained neurorepair and functional recovery remains elusive. Advances in stem cell engineering and regenerative medicine have opened new avenues for targeted interventions, particularly through the transplantation of neural stem/progenitor cells (NSPCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs). However, patient-specific factors such as cellular senescence, genetic and epigenetic variability, injury microenvironment, and comorbidities influence the efficacy of stem cell therapies by affecting graft survival and differentiation. Overcoming these challenges necessitates cutting-edge technologies, including single-cell transcriptomics, CRISPR-mediated hypoimmunogenic engineering, and biomaterial-based delivery platforms, which enable personalized and precision-driven SCI repair. Leveraging these advancements may help stem cell therapies overcome translational barriers and establish clinically viable regenerative solutions. This review explores the intersection of patient-specific variability, bioengineering innovations, and transcriptomic-guided precision medicine to define the next frontier in SCI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosciences, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Neuroscience Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
- Division of Neurosurgery, Department of Surgery, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
- Faculty of Health Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
ORCID-Profile: Sasi Kumar Jagadeesan, Ryan Vimukthie Sandarage
Förderung
- Josette Robertson and Joan Johnston Family Foundation Fund
- Michael T. Richard Clinical Research Fellowship in Neurosurgery
- Department of Surgery at the University of Ottawa
- Society of Neurological Surgeons;RUNN Course Resident Award
- Society of Neurological Surgeons, RUNN Course Resident Award
Zitieren
APA
Jagadeesan, S. K., Sandarage, R. V., Mathiyalagan, S., & Tsai, E. C. (2025). Personalized Stem Cell-Based Regeneration in Spinal Cord Injury Care. International Journal of Molecular Sciences, 26(8), 3874. https://doi.org/10.3390/ijms26083874
Vancouver
Jagadeesan SK, Sandarage RV, Mathiyalagan S, Tsai EC. Personalized Stem Cell-Based Regeneration in Spinal Cord Injury Care. International Journal of Molecular Sciences. 2025;26(8):3874. doi:10.3390/ijms26083874
BibTeX
@article{Jagadeesan2025,
author = {Jagadeesan, Sasi Kumar and Sandarage, Ryan Vimukthie and Mathiyalagan, Sathya and Tsai, Eve Chung},
title = {Personalized Stem Cell-Based Regeneration in Spinal Cord Injury Care},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3874},
doi = {10.3390/ijms26083874}
}
EUVIMED